Assessing the immunogenicity of pneumococcal vaccination given as soon as possible after diagnosis to children and adolescents with leukaemia

Trial Profile

Assessing the immunogenicity of pneumococcal vaccination given as soon as possible after diagnosis to children and adolescents with leukaemia

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 22 Jun 2016

At a glance

  • Drugs Pneumococcal 10-valent vaccine conjugate (Primary)
  • Indications Pneumococcal infections
  • Focus Pharmacodynamics
  • Acronyms PreventIPD
  • Most Recent Events

    • 26 Apr 2011 Status changed from recruiting to active, no longer recruiting as reported by Australian New Zealand Clinical Trials Registry.
    • 10 Jul 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top